Medical comms - Articles

The field of oncology is advancing rapidly with innovative anti-tumor therapeutics that enhance efficacy and reduce side effects through technologies like liposomes and albumin-bound formulations.
In the rapidly evolving field of oncology, the development of advanced anti-tumor therapeutics continues to offer new hope for patients battling various forms of cancer. As global healthcare systems grapple with rising cancer incidences, pharmaceutical innovations—particularly in targeted drug delivery systems like liposomes and albumin-bound formulations—are playing a pivotal role in improving treatment efficacy while minimizing side effects. This article explores key advancements in anti-tumor products, highlighting how these formulations are transforming cancer care and the importance of effici…

China’s pharmaceutical export sector is experiencing a significant transformation, evolving from a primary supplier of generic drugs and raw materials to a global exporter of high-value, innovative therapies. This strategic shift is driven by massive R&D investments and regulatory harmonization with international standards. Major players like Sinopharm, Shanghai Pharmaceuticals, and Jiangsu Hengrui are crucial for global access to essential medicines and new oncology treatments. Specialized wholesalers, including Hong Kong DengYue Medicine Limited, are also vital, focusing on the trade of rare and specialty drugs. This new focus positions Chinese companies as key partners in both commodity supply and cutting-edge biomedical innovation worldwide, boosting global health security and therapeutic diversity.

In longitudinal clinical trials, missing data is a threat to scientific integrity. Whether due to patient dropouts, missed visits, or protocol deviations, these gaps can distort results, reduce statistical power, and invite regulatory scrutiny. With dropout rates averaging around 3-8% for the last three years, the stakes are high. As the industry continues to evolve, so should the strategies we implement.
In longitudinal clinical trials, missing data is a threat to scientific integrity. Whether due to patient dropouts, missed visits, or protocol deviations, these gaps can distort results, reduce statistical power, and invite regulatory scrutiny. With dropout rates averaging around 3-8% for the last three years, the stakes are high. As the industry continues to evolve, so should the str…

The global Penicillin Active Pharmaceutical Ingredients (API) market was valued at USD 2.95 billion in 2023 and is projected to reach USD 4.79 billion by 2032, growing at a CAGR of 5.6%. This growth is driven by the increasing demand for antibiotics, advancements in manufacturing technologies, and the expansion of healthcare infrastructure in emerging economies. The report provides an in-depth analysis of market trends, key players, and regional dynamics, offering valuable insights for stakeholders in the pharmaceutical industry.
The Penicillin Active Pharmaceutical Ingredients (APIs) market represents a cornerstone of the global pharmaceutical industry, providing the essential building blocks for antibiotics that combat a wide range of bacterial infections. With its critical role in health…

The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during the HIV/AIDS epidemic to provide faster access to life-saving treatments, has been instrumental in expediting access to therapies for serious and life-threatening conditions. It is particularly significant in therapeutic areas, such as rare diseases, where surrogate or intermediate clinical endpoints may be necessary due to limited patient populations or slow disease progression. While this approach has encouraged innovation, it has also raised concerns about drugs staying on the market without confirmed evidence of their effectiveness.
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during…

Mobility equipment is often overlooked in elderly care, yet it plays a vital role in supporting independence, preventing falls, and improving health outcomes for seniors. From adjustable beds that aid circulation and breathing to scooters that reduce social isolation, assistive devices can significantly improve both physical and mental wellbeing. These solutions also ease the strain on carers, reducing injuries and stress in home and clinical settings. As healthcare systems look for ways to lower hospital admissions and promote preventive care, mobility equipment deserves recognition as an essential part of elderly care strategies. By making these tools more accessible, we can help older adults thrive while also reducing pressure on health services.
As populations age across the globe, heal…

The intimate wash care products industry is projected to grow steadily through 2032, driven by changing hygiene standards, rising awareness, and evolving consumer preferences. Explore trends, market share insights, and growth drivers.
In recent years, the global health and wellness industry has seen an unprecedented evolution—not only in mainstream personal care but also in intimate hygiene. Among the most dynamic and increasingly visible segments is the intimate wash care products category, which has transitioned from niche awareness to everyday consumer routines in many parts of the world. As per data released by Acumen Research and Consulting, the global intimate wash care product market was valued at USD 28.6 billion in 2023 and is projected to reach USD 45.9 billion by 2032, expanding…

Examine the Regenerative Medicine Scaffolds Market growth—from USD 336.5 Million in 2023 to USD 1.72 Billion by 2032 at a 20.2% CAGR. Learn key trends, technology advances, regional dynamics, and tissue repair innovations reshaping healthcare.
Biomaterials engineered to restore, replace, or augment damaged tissues are gaining momentum—and at the core are Regenerative Medicine Scaffolds, critical in advancing tissue repair across orthopedics, neurology, wound healing, and cardiovascular applications. Our recent analysis at Acumen Research & Consulting sheds light on shifting market dynamics, emerging technologies, and region-wise growth projections. Market Size & Growth Outlook The Regenerative Medicine Scaffolds Market Size reached USD 336.5 million in 2023 and is forecast to so…

The MD-42 License, issued by India’s Central Licensing Authority, is mandatory for manufacturing Class C and D medical devices like stents and implants. To obtain it, manufacturers must have ISO 13485-compliant facilities, qualified staff, and follow GMP. The application involves submitting detailed documentation via the CDSCO SUGAM portal, paying fees, and passing inspections. Valid for 5 years, the MD-42 License ensures regulatory compliance, builds trust, and enables market access. Expert assistance can simplify the process and help avoid delays or rejections.
What is an MD-42 License? An MD-42 license is granted by the Central Licensing Authority (CLA) to manufacturers of Class C and D medical devices. This license ensures your products meet strict safety, quality, and performance stand…

The Medical Telepresence Robots Market is projected to grow from USD 66.2 million in 2023 to USD 322.1 million by 2032, at a CAGR of 19.3%. This growth is driven by the rise in telemedicine, healthcare professional shortages, aging populations, and the need for infection control. Key market trends include AI integration, 5G connectivity, and expanding use in hospitals, home care, and senior living. North America leads the market, with Asia-Pacific emerging as the fastest-growing region.
Medical Telepresence Robots Market Overview: Unlocking the Future of Remote Healthcare In an increasingly digital healthcare landscape, Medical Telepresence Robots are emerging as a game-changing solution to bridge gaps in care delivery, especially in underserved or geographically distant locations. Accordin…

Data sovereignty is becoming a strategic priority for UK organisations, influencing data centre decisions beyond just performance or cost. As regulations tighten and technologies like AI demand faster, local processing, businesses are turning to UK-based infrastructure for security, compliance, and competitive edge. From private cloud to high-performance data centres, keeping data close is now key to both innovation and risk management.
Data sovereignty has become a critical consideration for those selecting data centre solutions. The concept that data is governed by the legal frameworks of the country where it is stored or collected underpins two key legislative instruments: the Data Protection Act 2018 (DPA 2018) and the UK General Data Protection Regulation (UK GDPR).   While both l…

What would happen if pharmaceutical companies took an active role in educating the public on health-related topics? The possibility comes with pros and cons, but with a focus on efficacy and ethics, such an approach could benefit consumers.
Pharmaceutical experts are used to staying in labs or behind counters, handing customers their prescriptions. Their role in patients’ lives is significant yet understated, with most communications printed on informational leaflets about the medication’s impacts.  What would happen if pharmaceutical companies took an active role in educating the public on health-related topics? The possibility comes with pros and cons, but with a focus on efficacy and ethics, such an approach could benefit consumers.  What Education Could Pharmaceutical Compani…

Selling medical devices to hospitals can be a lucrative yet challenging endeavor. With the healthcare industry growing and the demand for medical devices and medical equipment increasing, understanding how to sell medical devices effectively is crucial. In this guide, we’ll share key strategies for selling medical devices to hospitals, from identifying high-value facilities to proving your knowledge of their needs. Whether you’re selling medical equipment online or engaging with doctors and hospitals directly, these tips will help you navigate the complexities of the healthcare market.
  Selling medical devices to hospitals can be a lucrative yet challenging endeavor. With the healthcare industry growing and the demand for medical devices and medical equipment increasing, unde…

Discover the ultimate guide to becoming a medical sales rep. Learn about different sales roles, including medical devices, pharmaceuticals, and healthcare software. Understand key responsibilities, essential skills, and how to meet industry compliance requirements. Find out how to gain relevant experience through internships, training programs, and sales roles. Learn the differences between inbound and outbound sales, and get tips on preparing for interviews to stand out in a competitive field. Explore the benefits of training programs like Medical Sales College, Medical Sales 101, and New To Medical Device Sales. With potential earnings of $68,000 to over $100,000 per year, this lucrative career offers substantial growth. Start your journey to building strong relationships with healthcare professionals and succeeding in the medtech industry today.

Discover the latest AI innovations transforming healthcare in 2025. From enhanced diagnostics and personalized patient care to operational efficiency, artificial intelligence is reshaping the medical landscape. Learn about top companies like Cleerly, Qure.ai, Owkin, Vitazi.ai, and Exscientia leading the charge with AI-powered solutions. This comprehensive overview also addresses critical challenges like data privacy, algorithm bias, and regulatory compliance. Alpha Sophia supports sales teams by making it easier to find doctors and engage early adopters, helping accelerate AI adoption across the healthcare industry. Find out how AI is redefining healthcare and how Alpha Sophia can help you reach the right audience faster.
AI in Healthcare: Key Innovations and 5 Companies to Watch in 2025…

Water for Injection is an essential component of pharmaceutical manufacturing, ensuring the safety and efficacy of products. From injectable drugs to vaccine production, WFI plays a critical role at every stage of the process, underscoring the need for precision, compliance, and innovation in its production and application. Swjal Process is a leading pharmaceutical-grade water generation and distribution plant manufacturer in India.
The Role of Water for Injection (WFI) in Pharmaceutical Manufacturing Water for Injection (WFI) serves as a cornerstone of pharmaceutical manufacturing, where the highest standards of quality and purity are paramount. Its use spans the production of injectable drugs, vaccines, and other critical healthcare products, requiring utmost precision and control to e…

According to a new report published today, urgent action is required to develop skills and retrain staff in the UK’s pharmaceutical sector to take advantage of a predicted boom in RNA medicines and treatments.
It highlights that the workforce could need at least 150 future capabilities to meet RNA vaccine and treatment demand.    This includes developing novel equipment and reagents to increase efficiencies within RNA therapeutics manufacturing. The report also highlights the need to enhance technical and digital capabilities so companies can scale up manufacturing.     The report urges the industry to plan for the future roles, novel equipment and capabilities needed to develop and provide innovative treatments and medicines.    Meanwhile, the industry s…

Calum Jones (Associate Director – Health Economics) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations
  Calum Jones (Associate Director – Health Economics) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations’. On 18th June, I had the distinct pleasure of participating in an expert panel at the HTAi annual meeting held in the picturesque city of Seville, Spain. The session, titled ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economi…

In an ever-evolving field like medical writing, versatility is not just a skill – it’s a necessity. As the demands of the healthcare sector grow increasingly complex, you should be looking for new ways to diversify your portfolio and effectively demonstrate your range of skills and depth of knowledge.
In an ever-evolving field like medical writing, versatility is not just a skill – it’s a necessity. As the demands of the healthcare sector grow increasingly complex, you should be looking for new ways to diversify your portfolio and effectively demonstrate your range of skills and depth of knowledge. A well-crafted, diverse portfolio will showcase your competence across various sub-disciplines, demonstrating your versatility and positioning you for success in the competitive 2024 job market. …

Mtech Access are now part of Petauri. This marks a significant and exciting milestone in our journey, and aligns with our commitment to partnering with industry to bring life-enhancing technologies to market, providing more patient choice and meeting the needs of the healthcare environment.
What this means for our clients: Enhanced services: This strategic move will allow us to offer greater breadth and depth of technical and consulting experience, as well as market coverage for our clients. Continuity and stability: The quality of work and client service that you have come to expect, along with your current projects and relationships, will remain unchanged. Innovative solutions: Leveraging the strengths of the Petauri group, we will build on our commitment to growth and inn…